세계의 부비강암 시장 보고서(2025년)

Paranasal Sinus Cancer Global Market Report 2025

US $ 4,490 ￦ 6,156,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 8,898,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,640,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

부비강암 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 6.7%로, 14억 4,000만 달러로 성장할 것으로 예상합니다. 예측기간의 성장은 면역요법 수요 증가, 헬스케어 지출 증가, 맞춤형 의료의 개발, 규제 당국의 지원과 희귀의약품의 지정, 노인의 확대 등에 기인하고 있습니다. 예측기간의 주요 동향으로는 암 진단에 있어서의 AI의 채택, 유전자 치료나 표적약의 진보, 저침습 수술의 확대, 리퀴드 바이옵시의 역할의 대두, 원격의료나 디지털 헬스툴의 이용 증가 등을 들 수 있습니다.

담배 사용량 증가는 향후 몇 년간의 부비강암 시장의 확대를 견인할 것으로 예측됩니다. 담배 소비는 담배, 시가, 무연 담배 등 다양한 제품을 포함하며, 모두 개인을 여러 발암 물질에 노출시킵니다. 담배 사용 증가는 세계 흡연률 증가, 담배 회사의 적극적인 마케팅, 사회 경제적 과제, 저소득 및 중소득 국가의 규제 강화 약점, 특정 지역의 문화적 수용 등의 요인에 영향을 받고 있습니다. 흡연은 점막을 손상시키고 종양 성장을 가속하는 유해한 화학물질을 초래하기 때문에 담배 사용률 증가는 부비강암의 위험을 증가시키고 있습니다. 담배 연기에 포함된 발암물질은 세포의 돌연변이와 염증을 일으켜 부비강암 위험을 더욱 높입니다. 예를 들어 2024년 9월 미국 정부기관인 질병대책예방센터(CDC)는 2022년 인구의 19.8%에 해당하는 약 4,920만명의 미국 성인이 담배 제품을 사용했다고 보고했습니다. 그 결과, 담배 소비량 증가가 부비강암 시장의 성장에 박차를 가하고 있습니다.

종양학의 조사와 의료에 대한 투자 증가도 부비강암 시장의 확대에 기여할 것으로 예측됩니다. 정밀의료의 진보, 혁신적인 치료법에 대한 수요 증가, 임상 검사의 확대, 정부와 민간 자금 제공 이니셔티브, 표적 요법과 면역 요법의 연구 개발에 의해 가져왔습니다. 약제의 임상 검사에 대한 자금 제공, 소아암 치료의 인프라 강화, 질환의 생물학적 성질이나 진행에 대해 보다 깊은 통찰을 얻기 위한 연구 촉진 등에 의해 부비강암의 진보를 지지하고 있습니다. 2024년 5월, 첨단 분석 전문 인도 기반 정보 기술 기업인 IQVIA는 전 세계 암 치료제 지출액이 2023년에 2,230억 달러에 달했으며, 이는 2022년 대비 250억 달러 증가한 수치라고 보고했습니다. 또한 2028년에는 4,090억 달러에 이를 것으로 전망했습니다. 따라서 종양학 연구와 의학에 대한 투자가 증가함에 따라 부비강암 시장의 성장이 가속화되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 부비강암 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업의 분석
• 세계의 부비강암 시장 : 성장률 분석
• 세계의 부비강암 시장 실적: 규모와 성장, 2019-2024년
• 세계의 부비강암 시장 예측 : 규모와 성장, 2024-2029년, 2034년
• 세계의 부비강암 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 부비강암 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 편평상피암
• 선암암
• 점표피암
• 기타
• 세계의 부비강암 시장 : 진단별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 병력과 신체검사
• 화상 검사
• 생검
• 기타
• 세계의 부비강암 시장 : 치료별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 수술
• 방사선치료
• 화학요법
• 표적요법
• 면역요법
• 세계의 부비강암 시장 : 최종사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 병원 및 클리닉
• 암 치료 연구센터
• 실험실
• 기타
• 세계의 부비강암 시장 : 편평상피암별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 각화 편평상피암
• 비각화 편평상피암
• 기저핵 편평상피암
• 세계의 부비강암 시장 : 선암별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 장형선암
• 비장관형선암
• 세계의 부비강암 시장 : 점표피암별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 저악성도 점 표피암
• 중악성도 점 표피암
• 고악성도 점 표피암
• 세계의 부비강암 시장 : 그 밖의 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 부비동 미분화 암
• 신경내분비암
• 땀샘 낭종암
• 흑색종
• 육종
• 림프종

제7장 지역별/국가별 분석

• 세계의 부비강암 시장 :지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 부비강암 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 부비강암 시장 : 경쟁 구도
• 부비강암 시장 : 기업 프로파일
  • Bristol-Myers Squibb
  • Penn Medicine
  • MD Anderson Cancer Center
  • RWJBarnabas Health
  • Mayo Foundation for Medical Education and Research

제31장 기타 주요 기업 및 혁신 기업

• Stanford Health Care
• Memorial Sloan Kettering Cancer Center
• Massachusetts General Hospital
• The University of Chicago Medical Center
• City of Hope
• Moffitt Cancer Center
• Northwestern Medicine
• UK Markey Cancer Center
• Karmanos Cancer Institute
• Dana-Farber Cancer Institute Inc.
• VCU Massey Cancer Center
• Vanderbilt-Ingram Cancer Center
• Fulgent Pharma
• Duke University Health System
• Montefiore Einstein Comprehensive Cancer Center

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

• 부비강암 시장, 2029년 : 새로운 기회를 제공하는 국가
• 부비강암 시장, 2029년 : 새로운 기회를 제공하는 부문
• 부비강암 시장, 2029년 : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제36장 부록

SHW

영문 목차

영문목차

Paranasal sinus cancer is a rare malignancy that originates in the air-filled cavities surrounding the nose. The primary goal of managing this cancer is early identification, diagnosis, and treatment to improve survival rates and enhance the patient's quality of life. Treatment focuses on eliminating or shrinking the tumor, preventing its spread, and alleviating symptoms such as pain and nasal blockage.

The main types of paranasal sinus cancer include squamous cell carcinoma, adenocarcinoma, mucoepidermoid carcinoma, and others. Squamous cell carcinoma arises from the squamous cells in the sinuses, often leading to nasal obstruction, pain, and other localized symptoms. Diagnosis involves medical history evaluation, physical examination, imaging tests, and biopsy. Treatment options include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. These treatments are utilized by various end-users, including hospitals and clinics, cancer treatment and research centers, and research laboratories.

The paranasal sinus cancer market research report is one of a series of new reports from The Business Research Company that provides paranasal sinus cancer market statistics, including the paranasal sinus cancer industry global market size, regional shares, competitors with the paranasal sinus cancer market share, detailed paranasal sinus cancer market segments, market trends, and opportunities, and any further data you may need to thrive in the paranasal sinus cancer industry. This personal emergency response system (PERS) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The paranasal sinus cancer market size has grown strongly in recent years. It will grow from $1.03 billion in 2024 to $1.11 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to advancements in radiation therapy, increasing awareness and early diagnosis, the expanding use of chemotherapy and targeted therapy, improved surgical techniques, and a rising incidence of occupational exposure-linked cases.

The paranasal sinus cancer market size is expected to see strong growth in the next few years. It will grow to $1.44 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to the growing demand for immunotherapy, rising healthcare expenditure, the development of personalized medicine, regulatory support and orphan drug designations, and an expanding geriatric population. Major trends in the forecast period include the adoption of AI in cancer diagnosis, advancements in gene therapy and targeted drugs, the expansion of minimally invasive surgeries, the emerging role of liquid biopsies, and the increasing use of telemedicine and digital health tools.

The increasing use of tobacco is expected to drive the expansion of the paranasal sinus cancer market in the coming years. Tobacco consumption includes various products such as cigarettes, cigars, and smokeless tobacco, all of which expose individuals to multiple carcinogens. The rise in tobacco use is influenced by factors such as increasing global smoking rates, aggressive marketing by tobacco companies, socio-economic challenges, weak regulatory enforcement in low- and middle-income countries, and cultural acceptance in certain regions. The growing prevalence of tobacco use raises the risk of paranasal sinus cancer, as smoking introduces harmful chemicals that damage mucous membranes and encourage tumor growth. Carcinogens in tobacco smoke contribute to cellular mutations and inflammation, further increasing cancer risk in the sinuses. For example, in September 2024, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported that approximately 49.2 million U.S. adults, or 19.8% of the population, used tobacco products in 2022. As a result, the rising tobacco consumption is fueling the growth of the paranasal sinus cancer market.

Increasing investments in oncology research and medicine are also expected to contribute to the expansion of the paranasal sinus cancer market. These investments, made by governments, pharmaceutical companies, research institutions, and private investors, aim to advance the understanding, prevention, diagnosis, and treatment of cancer. The rise in oncology research funding is driven by the growing global cancer burden, advancements in precision medicine, increasing demand for innovative therapies, expansion of clinical trials, government and private funding initiatives, and the development of targeted and immunotherapy treatments. Such investments support progress in paranasal sinus cancer by improving early diagnosis, enhancing treatment options such as targeted therapies and immunotherapy, funding clinical trials for more effective drugs, strengthening pediatric cancer care infrastructure, and fostering research to gain deeper insights into the disease's biology and progression. For instance, in May 2024, IQVIA, an India-based information technology company specializing in advanced analytics, reported that global spending on cancer medicine rose to $223 billion in 2023, a $25 billion increase from 2022, and is projected to reach $409 billion by 2028. Consequently, increasing investments in oncology research and medicine are accelerating the growth of the paranasal sinus cancer market.

The rise in clinical trials is key factor driving the expansion of the paranasal sinus cancer market. Clinical trials are research studies conducted to assess the safety, effectiveness, and potential benefits of new treatments or therapies in humans. The growing number of clinical trials is driven by advancements in medical research, the demand for innovative treatments, the increasing prevalence of chronic diseases, regulatory support, and expanding investments in biotechnology and pharmaceutical industries. The surge in clinical trials for paranasal sinus cancer accelerates the development of improved treatments, enhances understanding of the disease, and evaluates innovative therapies. This contributes to better patient outcomes, reduced side effects, and advancements in cancer care. For example, in November 2023, the Association of the British Pharmaceutical Industry, a UK-based trade association, reported that the total number of industry-sponsored clinical trials launched in the UK increased by 4.3%, from 394 trials in 2021 to 411 in 2022. As a result, the growing number of clinical trials is driving the advancement of the paranasal sinus cancer market.

Major players in the paranasal sinus cancer market are Bristol-Myers Squibb, Penn Medicine, MD Anderson Cancer Center, RWJBarnabas Health, Mayo Foundation for Medical Education and Research, Stanford Health Care, Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital, The University of Chicago Medical Center, City of Hope, Moffitt Cancer Center, Northwestern Medicine, UK Markey Cancer Center, Karmanos Cancer Institute, Dana-Farber Cancer Institute Inc., VCU Massey Cancer Center, Vanderbilt-Ingram Cancer Center, Fulgent Pharma, Duke University Health System, Montefiore Einstein Comprehensive Cancer Center.

North America was the largest region in the paranasal sinus cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in paranasal sinus cancer report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the paranasal sinus cancer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The paranasal sinus cancer market consists of revenues earned by entities providing services such as palliative and supportive care, and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The paranasal sinus cancer market also includes sales of chemotherapy agents, radiopharmaceuticals, and supportive care products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Paranasal Sinus Cancer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on paranasal sinus cancer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for paranasal sinus cancer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The paranasal sinus cancer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Squamous Cell Carcinoma; Adenocarcinoma; Mucoepidermoid Carcinoma; Other Types
• 2) By Diagnosis: Medical History And Physical Examination; Imaging Tests; Biopsy; Other Diagnosis
• 3) By Treatment: Surgery; Radiation Therapy; Chemotherapy; Targeted Therapy; Immunotherapy
• 4) By End-User: Hospital And Clinics; Cancer Treatment And Research Center; Research Laboratories; Other End-Users
• Subsegments:
• 1) By Squamous Cell Carcinoma: Keratinizing Squamous Cell Carcinoma; Non-Keratinizing Squamous Cell Carcinoma; Basaloid Squamous Cell Carcinoma
• 2) By Adenocarcinoma: Intestinal-Type Adenocarcinoma; Non-Intestinal-Type Adenocarcinoma
• 3) By Mucoepidermoid Carcinoma: Low-Grade Mucoepidermoid Carcinoma; Intermediate-Grade Mucoepidermoid Carcinoma; High-Grade Mucoepidermoid Carcinoma
• 4) By Other Types: Sinonasal Undifferentiated Carcinoma; Neuroendocrine Carcinoma; Adenoid Cystic Carcinoma; Melanoma; Sarcomas; Lymphoma
• Companies Mentioned:Bristol-Myers Squibb; Penn Medicine; MD Anderson Cancer Center; RWJBarnabas Health; Mayo Foundation for Medical Education and Research
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Paranasal Sinus Cancer Market Characteristics

3. Paranasal Sinus Cancer Market Trends And Strategies

4. Paranasal Sinus Cancer Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Paranasal Sinus Cancer Growth Analysis And Strategic Analysis Framework

• 5.1. Global Paranasal Sinus Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Paranasal Sinus Cancer Market Growth Rate Analysis
• 5.4. Global Paranasal Sinus Cancer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Paranasal Sinus Cancer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Paranasal Sinus Cancer Total Addressable Market (TAM)

6. Paranasal Sinus Cancer Market Segmentation

• 6.1. Global Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Squamous Cell Carcinoma
• Adenocarcinoma
• Mucoepidermoid Carcinoma
• Other Types
• 6.2. Global Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical History And Physical Examination
• Imaging Tests
• Biopsy
• Other Diagnosis
• 6.3. Global Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgery
• Radiation Therapy
• Chemotherapy
• Targeted Therapy
• Immunotherapy
• 6.4. Global Paranasal Sinus Cancer Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital And Clinics
• Cancer Treatment And Research Center
• Research Laboratories
• Other End-Users
• 6.5. Global Paranasal Sinus Cancer Market, Sub-Segmentation Of Squamous Cell Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Keratinizing Squamous Cell Carcinoma
• Non-Keratinizing Squamous Cell Carcinoma
• Basaloid Squamous Cell Carcinoma
• 6.6. Global Paranasal Sinus Cancer Market, Sub-Segmentation Of Adenocarcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intestinal-Type Adenocarcinoma
• Non-Intestinal-Type Adenocarcinoma
• 6.7. Global Paranasal Sinus Cancer Market, Sub-Segmentation Of Mucoepidermoid Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Low-Grade Mucoepidermoid Carcinoma
• Intermediate-Grade Mucoepidermoid Carcinoma
• High-Grade Mucoepidermoid Carcinoma
• 6.8. Global Paranasal Sinus Cancer Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sinonasal Undifferentiated Carcinoma
• Neuroendocrine Carcinoma
• Adenoid Cystic Carcinoma
• Melanoma
• Sarcomas
• Lymphoma

7. Paranasal Sinus Cancer Market Regional And Country Analysis

• 7.1. Global Paranasal Sinus Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Paranasal Sinus Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Paranasal Sinus Cancer Market

• 8.1. Asia-Pacific Paranasal Sinus Cancer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Paranasal Sinus Cancer Market

• 9.1. China Paranasal Sinus Cancer Market Overview
• 9.2. China Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Paranasal Sinus Cancer Market

• 10.1. India Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Paranasal Sinus Cancer Market

• 11.1. Japan Paranasal Sinus Cancer Market Overview
• 11.2. Japan Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Paranasal Sinus Cancer Market

• 12.1. Australia Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Paranasal Sinus Cancer Market

• 13.1. Indonesia Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Paranasal Sinus Cancer Market

• 14.1. South Korea Paranasal Sinus Cancer Market Overview
• 14.2. South Korea Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Paranasal Sinus Cancer Market

• 15.1. Western Europe Paranasal Sinus Cancer Market Overview
• 15.2. Western Europe Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Paranasal Sinus Cancer Market

• 16.1. UK Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Paranasal Sinus Cancer Market

• 17.1. Germany Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Paranasal Sinus Cancer Market

• 18.1. France Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Paranasal Sinus Cancer Market

• 19.1. Italy Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Paranasal Sinus Cancer Market

• 20.1. Spain Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Paranasal Sinus Cancer Market

• 21.1. Eastern Europe Paranasal Sinus Cancer Market Overview
• 21.2. Eastern Europe Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Paranasal Sinus Cancer Market

• 22.1. Russia Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Paranasal Sinus Cancer Market

• 23.1. North America Paranasal Sinus Cancer Market Overview
• 23.2. North America Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Paranasal Sinus Cancer Market

• 24.1. USA Paranasal Sinus Cancer Market Overview
• 24.2. USA Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Paranasal Sinus Cancer Market

• 25.1. Canada Paranasal Sinus Cancer Market Overview
• 25.2. Canada Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Paranasal Sinus Cancer Market

• 26.1. South America Paranasal Sinus Cancer Market Overview
• 26.2. South America Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Paranasal Sinus Cancer Market

• 27.1. Brazil Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Paranasal Sinus Cancer Market

• 28.1. Middle East Paranasal Sinus Cancer Market Overview
• 28.2. Middle East Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Paranasal Sinus Cancer Market

• 29.1. Africa Paranasal Sinus Cancer Market Overview
• 29.2. Africa Paranasal Sinus Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Paranasal Sinus Cancer Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Paranasal Sinus Cancer Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Paranasal Sinus Cancer Market Competitive Landscape And Company Profiles

• 30.1. Paranasal Sinus Cancer Market Competitive Landscape
• 30.2. Paranasal Sinus Cancer Market Company Profiles
  • 30.2.1. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Penn Medicine Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. MD Anderson Cancer Center Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. RWJBarnabas Health Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Mayo Foundation for Medical Education and Research Overview, Products and Services, Strategy and Financial Analysis

31. Paranasal Sinus Cancer Market Other Major And Innovative Companies

• 31.1. Stanford Health Care
• 31.2. Memorial Sloan Kettering Cancer Center
• 31.3. Massachusetts General Hospital
• 31.4. The University of Chicago Medical Center
• 31.5. City of Hope
• 31.6. Moffitt Cancer Center
• 31.7. Northwestern Medicine
• 31.8. UK Markey Cancer Center
• 31.9. Karmanos Cancer Institute
• 31.10. Dana-Farber Cancer Institute Inc.
• 31.11. VCU Massey Cancer Center
• 31.12. Vanderbilt-Ingram Cancer Center
• 31.13. Fulgent Pharma
• 31.14. Duke University Health System
• 31.15. Montefiore Einstein Comprehensive Cancer Center

32. Global Paranasal Sinus Cancer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Paranasal Sinus Cancer Market

34. Recent Developments In The Paranasal Sinus Cancer Market

35. Paranasal Sinus Cancer Market High Potential Countries, Segments and Strategies

• 35.1 Paranasal Sinus Cancer Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Paranasal Sinus Cancer Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Paranasal Sinus Cancer Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료